AEM
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sidwell, R. W.
Right arrow Articles by Schabel, F. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sidwell, R. W.
Right arrow Articles by Schabel, F. M., Jr.
Agricola
Right arrow Articles by Sidwell, R. W.
Right arrow Articles by Schabel, F. M.

 Previous Article  |  Next Article 

Appl Environ Microbiol. 1968 February; 16(2): 370-392
Copyright © 1968 American Society for Microbiology. All Rights Reserved.

In Vivo Antiviral Properties of Biologically Active Compounds

II. Studies with Influenza and Vaccinia Viruses

Robert W. Sidwell, Glen J. Dixon, Sara M. Sellers and Frank M. Schabel Jr.

Virus Section, Southern Research Institute, Birmingham, Alabama 35205

ABSTRACT

The in vivo anti-influenza virus and antivaccinia virus activity of 156 biologically active compounds was determined. One of two criteria was used for evaluating activity against the influenza virus. The criteria were increase in survivor number and mean survival time, and reduction in virus-induced lung consolidation in treated, infected Swiss mice. Increase in survivor number and mean survival time were the criteria for evaluation of antivaccinia virus activity. Several drug doses were tested against two virus concentrations to demonstrate antiviral activity more clearly. Two compounds were considered significantly active against the influenza virus: DL-noformicin (NSC 72942) and amantadine hydrochloride (NSC 83653). Eleven compounds had reproducible activity against vaccinia virus: isatin-ß-thiosemicarbazone (NSC 721), 6-azauracil (NSC 3425), 9-{alpha}-fluoro-2{alpha}-methylhydrocortisone 21-acetate (NSC 12601), 5-[bis(2-chloroethyl)amino]uracil (NSC 34462), 5-iodo-2'-deoxyuridine (NSC 39661), streptonigrin (NSC 45383), N-methylisatin ß-thiosemicarbazone (NSC 69811), cytovirin (NSC 91770), 9-ß-D-arabinofuranosyladenine (NSC 404241), and 5-(mercaptomethyl)uracil (NSC 529351).

Appl Environ Microbiol. 1968 February; 16(2): 370-392
Copyright © 1968 American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Microbiol. Mol. Biol. Rev. Eukaryot. Cell All ASM Journals

Copyright © 1968 by the American Society for Microbiology. All rights reserved.